How to Source DACLATASVIR+SOFOSBUVIR TABLET for Pharmaceutical Formulation
DACLATASVIR+SOFOSBUVIR TABLET (Tablets, 60+400mg) is classified under Hepatitis. It is therapeutically aligned with reference brands such as Hepcinat Plus. This guide highlights key sourcing factors buyers should consider when procuring high-quality DACLATASVIR+SOFOSBUVIR TABLET for formulation, R&D, or bulk manufacturing.
Product Overview:
This is a combination medication containing Daclatasvir 60mg and Sofosbuvir 400mg. It is used to treat chronic hepatitis C infection in adults. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV).
Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transpl...
DACLATASVIR+SOFOSBUVIR TABLET API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
DACLATASVIR+SOFOSBUVIR TABLET must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for DACLATASVIR+SOFOSBUVIR TABLET is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing DACLATASVIR+SOFOSBUVIR TABLET is more than procurement—it’s a strategic partnership. With its tablets form and 60+400mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing DACLATASVIR+SOFOSBUVIR TABLET.
Request a Quote
Frequently Asked Questions For Sourcing of DACLATASVIR+SOFOSBUVIR TABLET
What is the typical lead time for DACLATASVIR+SOFOSBUVIR TABLET?
Lead times range from 4–6 weeks depending on supplier and region.
Is DACLATASVIR+SOFOSBUVIR TABLET available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does DACLATASVIR+SOFOSBUVIR TABLET require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for DACLATASVIR+SOFOSBUVIR TABLET?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of DACLATASVIR+SOFOSBUVIR TABLET?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for DACLATASVIR+SOFOSBUVIR TABLET?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is DACLATASVIR+SOFOSBUVIR TABLET suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can DACLATASVIR+SOFOSBUVIR TABLET be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.